PATENT CLAIM ANALYSIS

Application Number: 15765824
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "04400A"]

Abstract:
Disclosed are methods of treating a head and/or neck squamous cell carcinoma in an individual. The method may include the step of administering to an individual a composition comprising an interleukin-1 receptor-associated kinase 1 (IRAK1) inhibitor, which may include inhibitors that inhibit IL-1 receptor-associated kinase 1 in addition to other IL-1 receptor-associated kinases, such as, for example, an IRAK1/4 inhibitor.

Claim (Index 16):
A kit comprising\n a. a composition comprising an agent selected from an IRAK1, and IRAK1/4 inhibitor, an inhibitor of DEK, and a combination thereof and a pharmaceutically acceptable carrier; and b. a means for delivery of the composition to a human.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 91.0
- Lexical Diversity: 1.41667
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14284521', '15288402', '14842049', '14604310', '14367837']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7425499859928062
- 35 USC 102 Novelty (BERT): 0.5015399269816341
- Combined Prediction Score: 0.718448980091689
- Mean Citation Score: 214.531664
- Max Citation Score: 223.97466
- Similarity Product: 144.9247580118799

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test